Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2026-01-02 @ 9:59 AM
Study NCT ID:
NCT01772368
Status:
COMPLETED
Last Update Posted:
2017-06-12
First Post:
2013-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FSS-AS-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None